ALS News Today20h
Voyager Therapeutics reassesses SOD1-ALS gene therapy program
The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...
Moderna price target lowered to $78 from $96 at UBS
UBS lowered the firm’s price target on Moderna (MRNA) to $78 from $96 and keeps a Buy rating on the shares. UBS believes Moderna’s oncology ...
Covid vaccine faces ban for all Americans in radical U-turn
Dr Jay Bhattacharya is one of the signatories of an online petition that claims there is a 'casual link' between the mRNA ...
Trump Blocks Federal Funds for Schools That Require COVID Vaccines
TUESDAY, Feb. 18, 2025 (HealthDay News) -- President Donald Trump signed an executive order withholding funding from schools ...
Trump's Aid Cuts Stop South African HIV Vaccine Trials in Their Tracks
A trial of an earlier, separate vaccine candidate, which was about to be tested on humans in South Africa as well as Kenya ...
Bernstein Reaffirms Their Hold Rating on Moderna (MRNA)
Bernstein analyst Courtney Breen maintained a Hold rating on Moderna (MRNA – Research Report) on February 14 and set a price target of $45.00.
thearabianpost4d
Global fashion icon Tia Lee Graces the Cover of ELLE Singapore, Reflects on Music, Empowerment, and Fashion
TAIPEI, TAIWAN - Media OutReach Newswire - 12 February 2025 - Global fashion and music icon Tia Lee (Lee Yu Fen) recently appeared on the cover of ELLE Singapore, celebrating her journey as an artist, ...
Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
Moderna Norovirus Vaccine Trial on Hold by US FDA Over Neurological Side Effect
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced U.S. President Donald ...